fda tirzepatide shortage update Response to Notification : r/tirzepatidecompound FDA Proposes Ban on Bulk
Description
Patients with certain genetic profiles may maintain weight more effectively on lower tirzepatide doses, while others benefit from consistent full-dose use
Whether that means restarting tirzepatide, exploring newer options like orforglipron , or consulting with your provider about alternative strategies, knowing the plan in advance removes the emotional decision-making that accompanies weight regain
Tirzepatide (Generic Mounjaro): A dual GLP-1 and GIP receptor agonist, FDA-approved for type 2 diabetes and used off-label for weight loss
Any significant change in your health or medication should be shared with your mental health team

KDIGO CKD Work Group (2024) KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease
